Over thousands of years, the aboriginal people of Australia used the resin of this Australian family of flowering plants, whose name in the local language means “desert loving”, and it was included in traditional smoking ceremonies, as it was believed to be beneficial for health, as it was used in the treatment of skin diseases. .
At a time when the resistance of cancerous tumors to drugs is a major obstacle to treatments such as chemotherapy, it has become necessary for scientists to open new doors to overcome this medical dilemma.
Recently, scientists have been studying “Erimophila galetta” plants at the biochemical level in order to learn more about their therapeutic secrets.
For many years, this type of plant has had promising therapeutic opportunities, not only because it has a long history of medicinal use but also because it contains flavonoids.
Flavonoids are a type of plant compound that has been shown to inhibit drug-resistant carrier proteins. These compounds are non-toxic, possess a high chemical versatility, and have promising bioactivity, making them valuable for medicinal use.
In the past, other species of the genus Eremophila have been found to contain flavonoids that inhibit the activity of drug-resistant transporter proteins, and some of these plants also exhibit antidiabetic, antiviral, antibacterial, and anti-inflammatory properties.
The researchers found that the resin taken from the plants “Erimophila galetta” was able to significantly increase the effect of chemotherapy on colon cancer cells, and tests revealed that the flavonoids in the resin undermined the action of proteins that block the delivery of drugs to cancer cells.
The authors of the current study say that if the results of the study are used to make a commercial product, they “consider sharing the profits with local farmers in the areas where these plants grow”.